The effect of combined PD-1/PD-L1 and extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor treatment was investigated of cell growth and intracellular impact of breast cancer cell lines.
[Journal of Cancer Research and Clinical Oncology]
7992332
MCW65KF6
items
1
apa
0
default
asc
1
164162
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/